Patrícia Recordon-Pinson

Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

Patrícia Recordon-Pinson, Cathia Soulié, Philippe Flandre et al. · Antimicrobial Agents and Chemotherapy · 2010 · 74 citations · Full text

Public Health, Pharmacology, Molecular Virology +14

Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors

Marie-Pierre Lézé, Marc Le Borgne, Patrícia Recordon-Pinson et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Slim Fourati, Charlotte Charpentier, Corinne Amiel et al. · Journal of Antimicrobial Chemotherapy · 2015 · 58 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Molecular Characterization of HIV Type 1 Isolates from Untreated Patients of Mumbai (Bombay), India, and Detection of Rare Resistance Mutations

Alaka Deshpande, Patrícia Recordon-Pinson, Ranjana Deshmukh et al. · AIDS Research and Human Retroviruses · 2004 · 57 citations

Life Sciences, Molecular Biology, Molecular Genetics +16

Resistance Mutations in Subtype C HIV Type 1 Isolates from Indian Patients of Mumbai Receiving NRTIs Plus NNRTIs and Experiencing a Treatment Failure: Resistance to AR

Alaka Deshpande, Valérie Jauvin, Noël Magnin et al. · AIDS Research and Human Retroviruses · 2007 · 56 citations

Life Sciences, Microbiology, Molecular Genetics +17